![Stefan-Erik von Euw](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefan-Erik von Euw
Directeur/Membre du Conseil chez NovaHep AB
Profil
Stefan-Erik von Euw is currently a Director at NovaHep AB.
Previously, he was a Director at Recopharma AB and a Managing Partner at Alden Impact Capital AG from 2011 to 2017.
Postes actifs de Stefan-Erik von Euw
Sociétés | Poste | Début |
---|---|---|
NovaHep AB
![]() NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Stefan-Erik von Euw
Sociétés | Poste | Fin |
---|---|---|
Alden Impact Capital AG
![]() Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011. | Private Equity Investor | 31/12/2017 |
Recopharma AB
![]() Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Alden Impact Capital AG
![]() Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011. | Finance |
Recopharma AB
![]() Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
NovaHep AB
![]() NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |